Experimental murine model of disseminated infection by Saksenaea vasiformis: successful treatment with posaconazole

Med Mycol. 2012 Oct;50(7):710-5. doi: 10.3109/13693786.2012.673137. Epub 2012 Mar 29.

Abstract

We have determined the in vitro activity of amphotericin B (AMB) and posaconazole (PSC) against Saksenaea vasiformis using broth microdilution and disk diffusion methods and determined the minimal fungicidal concentration (MFC). PSC was found to have the greatest in vitro activity in all cases and was the most efficacious in prolonging survival and reducing the fungal load in an immunocompetent murine model of disseminated infection caused by four strains of the fungus.

MeSH terms

  • Amphotericin B / pharmacology
  • Amphotericin B / therapeutic use
  • Animals
  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use*
  • Disease Models, Animal*
  • Male
  • Mice
  • Microbial Sensitivity Tests
  • Mucorales / pathogenicity*
  • Mucormycosis / drug therapy*
  • Mucormycosis / microbiology*
  • Mucormycosis / pathology*
  • Treatment Outcome
  • Triazoles / pharmacology
  • Triazoles / therapeutic use*

Substances

  • Antifungal Agents
  • Triazoles
  • posaconazole
  • Amphotericin B